1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Matthew Bucknor: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS) - Undifferentiated Pleomorphic Sarcoma | Not applicable | Terminated | Matthew Bucknor | 5 | 2020-01-23 | 2026-06-01 |
| Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas MRgFUS, CTgRFA - Osteoid Osteoma | Phase 3 | Recruiting | Matthew Bucknor | 56 | 2017-03-28 | 2025-02-19 |
Histiocytoma, Malignant Fibrous (1) · Osteoma, Osteoid (1) · Sarcoma (1)
United States (2)